Investing in Life Sciences Technology
Biospring Partners was founded in 2020 by Michelle Dipp, MD PhD and Jennifer Lum to invest in growth-stage life sciences technology companies. Biospring leverages its deep experience in the life sciences and technology industries to support B2B services, tools, and enterprise software companies that are driving innovation across the life sciences industry and beyond.
PathAI Announces Completion of $165 Million Financing
PathAI will deploy its new capital to accelerate product development while continuing to prioritize the improvement of patient outcomes with reliable AI-powered technology and meaningful collaboration with pharmaceutical and diagnostic partners.